Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting

Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the ...

Adaptive Biotechnologies to Participate in Jefferies Fireside Chat Series on Minimal Residual Disease

Adaptive Biotechnologies (“we” or “our”) is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment ...
eLife

Trained immunity and immune priming in plants and invertebrates

An evolutionary perspective on immune priming across plants and invertebrates highlights the roles of microbiomes and epigenetic regulation in shaping innate immune memory with promising applications ...
The Bakersfield Californian

Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ®

Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical ...
EurekAlert!

Groundbreaking review explores the cross-talk between innate and adaptive immunity

A new review by Dr. Ruyuan Wang and an international team of researchers explores the complex interactions between the innate and adaptive immune systems, shedding light on regulatory mechanisms in ...

Adaptive Biotechnologies to Participate in Upcoming Investor Conferences

Detailed price information for Adaptive Biotechnologies Corp (ADPT-Q) from The Globe and Mail including charting and trades.
Scientific American

Smoking May Compromise Immune Health, Even Years After Quitting

Numerous factors shape how a person’s immune system reacts to infections and other challenges. Age, sex and genetics are fundamental contributors—as the COVID pandemic highlighted. Now a new study ...